Targacept
Biopharmaceutical company focused on drugs to treat CNS disorders by targeting neuronal nicotinic receptors
- Year invested 2002
- Investment Stage Growth
- Sectors
- Investment Status Current
- Website targacept.com
- Company Status IPO/Public (Nasdaq: TRGT)